Search Results for: UBC

1079 interactions involving UBC - ubiquitin C found:

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
SYPL1 synaptophysin like 1
TAB1 TGF-beta activated kinase 1 (MAP3K7) binding protein 1
  • NOD1/2 Signaling Pathway
  • FCERI mediated NF-kB activation
  • TAK1-dependent IKK and NF-kappa-B activation
  • activated TAK1 mediates p38 MAPK activation
  • JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
  • TNFR1-induced NF-kappa-B signaling pathway
  • CLEC7A (Dectin-1) signaling
  • Ub-specific processing proteases
  • TICAM1,TRAF6-dependent induction of TAK1 complex
  • Interleukin-1 signaling
  • IRAK2 mediated activation of TAK1 complex
  • TRAF6-mediated induction of TAK1 complex within TLR4 complex
  • Alpha-protein kinase 1 signaling pathway
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
  • IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
  • Manganese
TAB2 TGF-beta activated kinase 1 (MAP3K7) binding protein 2
  • Nuclear signaling by ERBB4
  • Nuclear signaling by ERBB4
  • NOD1/2 Signaling Pathway
  • Downstream TCR signaling
  • FCERI mediated NF-kB activation
  • TAK1-dependent IKK and NF-kappa-B activation
  • activated TAK1 mediates p38 MAPK activation
  • JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
  • TNFR1-induced NF-kappa-B signaling pathway
  • CLEC7A (Dectin-1) signaling
  • TICAM1,TRAF6-dependent induction of TAK1 complex
  • Interleukin-1 signaling
  • IRAK2 mediated activation of TAK1 complex
  • TRAF6-mediated induction of TAK1 complex within TLR4 complex
  • Alpha-protein kinase 1 signaling pathway
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
  • IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
TAB3 TGF-beta activated kinase 1 (MAP3K7) binding protein 3
  • NOD1/2 Signaling Pathway
  • FCERI mediated NF-kB activation
  • TAK1-dependent IKK and NF-kappa-B activation
  • activated TAK1 mediates p38 MAPK activation
  • JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
  • TNFR1-induced NF-kappa-B signaling pathway
  • CLEC7A (Dectin-1) signaling
  • TICAM1,TRAF6-dependent induction of TAK1 complex
  • Interleukin-1 signaling
  • IRAK2 mediated activation of TAK1 complex
  • TRAF6-mediated induction of TAK1 complex within TLR4 complex
  • Alpha-protein kinase 1 signaling pathway
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
  • IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
TAC3 tachykinin precursor 3
  • Tachykinin receptors bind tachykinins
  • G alpha (q) signalling events
  • Copper
  • Hypogonadotropic hypogonadism; Kallmann syndrome (KAL)
TAF2 TATA-box binding protein associated factor 2
  • HIV Transcription Initiation
  • RNA Polymerase II HIV Promoter Escape
  • Transcription of the HIV genome
  • RNA Polymerase II Pre-transcription Events
  • Regulation of TP53 Activity through Phosphorylation
  • RNA Polymerase II Promoter Escape
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription Initiation
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
TAF6L TATA-box binding protein associated factor 6 like
  • HATs acetylate histones
TAPBP TAP binding protein
  • ER-Phagosome pathway
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Bare lymphocyte syndrome (BLS) type1
TAX1BP1 Tax1 binding protein 1
  • Regulation of TNFR1 signaling
  • Negative regulators of DDX58/IFIH1 signaling
TBC1D15 TBC1 domain family member 15
  • TBC/RABGAPs
TBC1D17 TBC1 domain family member 17
  • TBC/RABGAPs
TBC1D2 TBC1 domain family member 2
  • TBC/RABGAPs
TBC1D5 TBC1 domain family member 5
TBK1 TANK binding kinase 1
  • IRF3 mediated activation of type 1 IFN
  • IRF3 mediated activation of type 1 IFN
  • DDX58/IFIH1-mediated induction of interferon-alpha/beta
  • Regulation of innate immune responses to cytosolic DNA
  • STAT6-mediated induction of chemokines
  • IRF3-mediated induction of type I IFN
  • PINK1-PRKN Mediated Mitophagy
  • TNFR1-induced proapoptotic signaling
  • Regulation of TNFR1 signaling
  • Interleukin-37 signaling
  • TICAM1-dependent activation of IRF3/IRF7
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • Negative regulators of DDX58/IFIH1 signaling
  • Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE)
  • Potential therapeutics for SARS
  • SARS-CoV-1 activates/modulates innate immune responses
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
  • Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7
  • Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation
  • Fostamatinib
TBXAS1 thromboxane A synthase 1
  • Eicosanoids
  • Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
  • Defective TBXAS1 causes GHDD
  • Ridogrel
  • Dazoxiben
  • NM-702
  • Diaphyseal dysplasia with anemia (Ghosal)
TCAF1 TRPM8 channel associated factor 1
TCEAL1 transcription elongation factor A like 1
TCHH trichohyalin
  • Formation of the cornified envelope
TCOF1 treacle ribosome biogenesis factor 1
  • Treacher Collins syndrome
TCP10L3 t-complex 10 like 3 (pseudogene)

Page 42 out of 54 pages